Stocks News

LAST PRICE
272.8800
TODAY'S CHANGE (%)
Trending Down-3.6200 (-1.3092%)

Bid / Lots
267.8400/ 1
Ask / Lots
277.3500/ 1
Open / Previous Close
277.2700 / 276.5000
Day Range
Low 270.0200
High 277.2700
52 Week Range
Low 204.4400
High 279.9800
Volume
408,164
average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

May 21, 2024
- DJ United Therapeutics Is Maintained at Overweight by JP Morgan, from 12:23PM ET on Tuesday May 21, 2024 by Dow Jones
  12:23PM ET on Tuesday May 21, 2024 by Dow Jones
  Companies Mentioned: UTHR
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/UTHR/analyst-ratings
  
  (END) Dow Jones Newswires
  
  May 21, 2024 12:23 ET (16:23 GMT)
May 16, 2024
- United Therapeutics Insider Sold Shares Worth $545,800, According to a Recent SEC Filing, from 4:41PM ET on Thursday May 16, 2024 by MT Newswires
  4:41PM ET on Thursday May 16, 2024 by MT Newswires
  Companies Mentioned: UTHR
  04:41 PM EDT, 05/16/2024 (MT Newswires) -- Christopher Causey, Director, on May 15, 2024, sold 2,000 shares in United Therapeutics (UTHR) for $545,800. Following the Form 4 filing with the SEC, Causey has control over a total of 4,185 shares of the ...
May 14, 2024
- United Therapeutics Insider Sold Shares Worth $1,911,532, According to a Recent SEC Filing, from 4:39PM ET on Tuesday May 14, 2024 by MT Newswires
  4:39PM ET on Tuesday May 14, 2024 by MT Newswires
  Companies Mentioned: UTHR
  04:39 PM EDT, 05/14/2024 (MT Newswires) -- Martine A Rothblatt, Director, Chairperson & CEO, on May 10, 2024, sold 7,200 shares in United Therapeutics (UTHR) for $1,911,532. Following the Form 4 filing with the SEC, Rothblatt has control over a tota...
May 10, 2024
- United Therapeutics Insider Sold Shares Worth $1,898,393, According to a Recent SEC Filing, from 4:41PM ET on Friday May 10, 2024 by MT Newswires
  4:41PM ET on Friday May 10, 2024 by MT Newswires
  Companies Mentioned: UTHR
  04:41 PM EDT, 05/10/2024 (MT Newswires) -- Martine A Rothblatt, Director, Chairperson & CEO, on May 08, 2024, sold 7,200 shares in United Therapeutics (UTHR) for $1,898,393. Following the Form 4 filing with the SEC, Rothblatt has control over a tota...
May 8, 2024
- United Therapeutics Insider Sold Shares Worth $949,737, According to a Recent SEC Filing, from 5:15PM ET on Wednesday May 08, 2024 by MT Newswires
  5:15PM ET on Wednesday May 08, 2024 by MT Newswires
  Companies Mentioned: UTHR
  05:15 PM EDT, 05/08/2024 (MT Newswires) -- Martine A Rothblatt, Director, Chairperson & CEO, on May 07, 2024, sold 3,600 shares in United Therapeutics (UTHR) for $949,737. Following the Form 4 filing with the SEC, Rothblatt has control over a total ...

Today
- Sector Update: Health Care Stocks Advance Pre-Bell Friday, from 10 hours ago by MT Newswires
  10 hours ago by MT Newswires
  Companies Mentioned: EXAS, IBB, XLV, VSTM, GH
- Exact Sciences to Present New Data at Oncology Annual Meeting Confirming Prognostic Value of Breast Cancer Test, from 11 hours ago by MT Newswires
  11 hours ago by MT Newswires
  Companies Mentioned: EXAS
May 22, 2024
- Medpace Holdings Insider Sold Shares Worth $1,608,764, According to a Recent SEC Filing, from 4:29PM ET on Wednesday May 22, 2024 by MT Newswires
  4:29PM ET on Wednesday May 22, 2024 by MT Newswires
  Companies Mentioned: MEDP
May 21, 2024
- Neurocrine Biosciences Insider Sold Shares Worth $297,860, According to a Recent SEC Filing, from 5:35PM ET on Tuesday May 21, 2024 by MT Newswires
  5:35PM ET on Tuesday May 21, 2024 by MT Newswires
  Companies Mentioned: NBIX
- Exact Sciences Says Court Allows Patent Lawsuit Against Geneoscopy to Proceed, from 8:56AM ET on Tuesday May 21, 2024 by MT Newswires
  8:56AM ET on Tuesday May 21, 2024 by MT Newswires
  Companies Mentioned: EXAS
May 17, 2024
- Medpace Holdings Insider Sold Shares Worth $15,924,222, According to a Recent SEC Filing, from 4:17PM ET on Friday May 17, 2024 by MT Newswires
  4:17PM ET on Friday May 17, 2024 by MT Newswires
  Companies Mentioned: MEDP
- --Baird Downgrades BioMarin Pharmaceutical to Neutral From Outperform, Cuts Price Target to $72 From $104, from 7:29AM ET on Friday May 17, 2024 by MT Newswires
  7:29AM ET on Friday May 17, 2024 by MT Newswires
  Companies Mentioned: BMRN
May 16, 2024
- Neurocrine Biosciences Insider Sold Shares Worth $4,138,436, According to a Recent SEC Filing, from 4:47PM ET on Thursday May 16, 2024 by MT Newswires
  4:47PM ET on Thursday May 16, 2024 by MT Newswires
  Companies Mentioned: NBIX
May 14, 2024
- Medpace Holdings Insider Sold Shares Worth $1,996,723, According to a Recent SEC Filing, from 4:25PM ET on Tuesday May 14, 2024 by MT Newswires
  4:25PM ET on Tuesday May 14, 2024 by MT Newswires
  Companies Mentioned: MEDP
- Neurocrine Biosciences Presented Baseline Data from the CAHtalyst™ Program in CAH and Study Data for Modified-Release Hydrocortisone in Primary Adrenal Insufficiency and CAH at ECE 2024, from 8:30AM ET on Tuesday May 14, 2024 by PR Newswire
  8:30AM ET on Tuesday May 14, 2024 by PR Newswire
  Companies Mentioned: NBIX

United Therapeutics Corp
NASDAQ:UTHRUnited States

Search Criteria

May 21, 2024

DJ United Therapeutics Is Maintained at Overweight by JP Morgan, from 12:23PM ET on Tuesday May 21, 2024 by Dow Jones

May 16, 2024

United Therapeutics Insider Sold Shares Worth $545,800, According to a Recent SEC Filing, from 4:41PM ET on Thursday May 16, 2024 by MT Newswires

May 14, 2024

United Therapeutics Insider Sold Shares Worth $1,911,532, According to a Recent SEC Filing, from 4:39PM ET on Tuesday May 14, 2024 by MT Newswires

May 10, 2024

United Therapeutics Insider Sold Shares Worth $1,898,393, According to a Recent SEC Filing, from 4:41PM ET on Friday May 10, 2024 by MT Newswires

May 8, 2024

United Therapeutics Insider Sold Shares Worth $949,737, According to a Recent SEC Filing, from 5:15PM ET on Wednesday May 08, 2024 by MT Newswires

Peers Headlines

Today

Sector Update: Health Care Stocks Advance Pre-Bell Friday, from 10 hours ago by MT Newswires

Exact Sciences to Present New Data at Oncology Annual Meeting Confirming Prognostic Value of Breast Cancer Test, from 11 hours ago by MT Newswires

May 22, 2024

Medpace Holdings Insider Sold Shares Worth $1,608,764, According to a Recent SEC Filing, from 4:29PM ET on Wednesday May 22, 2024 by MT Newswires

May 21, 2024

Neurocrine Biosciences Insider Sold Shares Worth $297,860, According to a Recent SEC Filing, from 5:35PM ET on Tuesday May 21, 2024 by MT Newswires

Exact Sciences Says Court Allows Patent Lawsuit Against Geneoscopy to Proceed, from 8:56AM ET on Tuesday May 21, 2024 by MT Newswires

May 17, 2024

Medpace Holdings Insider Sold Shares Worth $15,924,222, According to a Recent SEC Filing, from 4:17PM ET on Friday May 17, 2024 by MT Newswires

--Baird Downgrades BioMarin Pharmaceutical to Neutral From Outperform, Cuts Price Target to $72 From $104, from 7:29AM ET on Friday May 17, 2024 by MT Newswires

May 16, 2024

Neurocrine Biosciences Insider Sold Shares Worth $4,138,436, According to a Recent SEC Filing, from 4:47PM ET on Thursday May 16, 2024 by MT Newswires

May 14, 2024

Medpace Holdings Insider Sold Shares Worth $1,996,723, According to a Recent SEC Filing, from 4:25PM ET on Tuesday May 14, 2024 by MT Newswires

Neurocrine Biosciences Presented Baseline Data from the CAHtalyst™ Program in CAH and Study Data for Modified-Release Hydrocortisone in Primary Adrenal Insufficiency and CAH at ECE 2024, from 8:30AM ET on Tuesday May 14, 2024 by PR Newswire